AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. SymBio Pharmaceuticals Limited
  3. Financials
  4. Revenue growth (%)

SymBio Pharmaceuticals Limited【JP:4582】

Market cap
¥7B
P/E ratio
-2x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
Dec 31, 2025-46.7-16.75%
Dec 31, 2024-56.1+27.11%
Dec 31, 2023-44.1-308.16%
Dec 31, 202221.2-87.98%
Dec 31, 2021176.4+3253.99%
Dec 31, 20205.3-120.22%
Dec 31, 2019-26-328.96%
Dec 31, 201811.4-75.00%
Dec 31, 201745.4+102.05%
Dec 31, 201622.5-2126.13%
Dec 31, 2015-1.1-104.02%
Dec 31, 201427.6-227.59%
Dec 31, 2013-21.6-660.62%
Dec 31, 20123.9

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)